Machiko Hoshino Selected Research

Cytokines

1/2007

NF-kappaB inhibitor dehydroxymethylepoxyquinomicin suppresses osteoclastogenesis and expression of NFATc1 in mouse arthritis without affecting expression of RANKL, osteoprotegerin or macrophage colony-stimulating factor.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Machiko Hoshino Research Topics

Disease

1	Arthritis (Polyarthritis) 01/2007
1	Rheumatoid Arthritis 01/2007
1	Inflammation (Inflammations) 01/2007

Drug/Important Bio-Agent (IBA)

1	dehydroxymethylepoxyquinomicinIBA 01/2007
1	Macrophage Colony-Stimulating FactorIBA 01/2007
1	CytokinesIBA 01/2007
1	NF-kappa B (NF-kB)IBA 01/2007
1	OsteoprotegerinIBA 01/2007

Therapy/Procedure

1	Therapeutics 01/2007